{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:31:43Z","timestamp":1764783103745,"version":"3.37.3"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1124\/mol.108.053660","type":"journal-article","created":{"date-parts":[[2009,3,14]],"date-time":"2009-03-14T00:53:53Z","timestamp":1236992033000},"page":"1392-1399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Regulation of Human Vitamin D3 25-Hydroxylases in Dermal Fibroblasts and Prostate Cancer LNCaP Cells"],"prefix":"10.1016","volume":"75","author":[{"given":"Maria","family":"Ellfolk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Norlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Gyllensten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kjell","family":"Wikvall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.108.053660_bib1","doi-asserted-by":"crossref","unstructured":"Aiba I, Yamasaki T, Shinki T, Izumi S, Yamamoto K, Yamada S, Terato H, Ide H, and Ohyama Y (2006) Characterization of rat and human CYP2J enzymes as vitamin D 25-hydroxylases. Steroids 71: 849-856.","DOI":"10.1016\/j.steroids.2006.04.009"},{"key":"10.1124\/mol.108.053660_bib2","doi-asserted-by":"crossref","unstructured":"Chang TK, Bandiera SM, and Chen J (2003) Constitutive androstane receptor and pregnane X receptor gene expression in human liver: interindividual variability and correlation with CYP2B6 mRNA levels. Drug Metab Dispos 31: 7-10.","DOI":"10.1124\/dmd.31.1.7"},{"key":"10.1124\/mol.108.053660_bib3","doi-asserted-by":"crossref","unstructured":"Cheng JB, Motola DL, Mangelsdorf DJ, and Russell DW (2003) De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxylase. J Biol Chem 278: 38084-38093.","DOI":"10.1074\/jbc.M307028200"},{"key":"10.1124\/mol.108.053660_bib4","doi-asserted-by":"crossref","unstructured":"Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, and Russell DW (2004) Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci U S A 101: 7711-7715.","DOI":"10.1073\/pnas.0402490101"},{"key":"10.1124\/mol.108.053660_bib5","doi-asserted-by":"crossref","unstructured":"Ellfolk M, Norlin M, and Wikvall K (2006) Isolation and properties of the CYP2D25 promoter: transcriptional regulation by vitamin D3 metabolites. Biochem Biophys Res Commun 345: 568-572.","DOI":"10.1016\/j.bbrc.2006.04.116"},{"key":"10.1124\/mol.108.053660_bib6","doi-asserted-by":"crossref","unstructured":"Garuti R, Lelli N, Barozzini M, Dotti MT, Federico A, Bertolini S, and Calandra S (1996) Partial deletion of the gene encoding sterol 27-hydroxylase in a subject with cerebrotendinous xanthomatosis. J Lipid Res 37: 662-672.","DOI":"10.1016\/S0022-2275(20)37607-0"},{"key":"10.1124\/mol.108.053660_bib7","doi-asserted-by":"crossref","unstructured":"Gupta RP, Hollis BW, Patel SB, Patrick KS, and Bell NH (2004) CYP3A4 is a human microsomal vitamin D 25-hydroxylase. J Bone Miner Res 19: 680-688.","DOI":"10.1359\/JBMR.0301257"},{"key":"10.1124\/mol.108.053660_bib8","doi-asserted-by":"crossref","unstructured":"Gyllensten K, Josephson F, Lidman K, and S\u00e4\u00e4f M (2006) Severe vitamin D deficiency diagnosed after introduction of antiretroviral therapy including efavirenz in a patient living at latitude 59. AIDS 20: 1906-1907.","DOI":"10.1097\/01.aids.0000244216.08327.39"},{"key":"10.1124\/mol.108.053660_bib9","doi-asserted-by":"crossref","unstructured":"Hakkola J, Pasanen M, Hukkanen J, Pelkonen O, M\u00e4enp\u00e4\u00e4 J, Edwards RJ, Boobis AR, and Raunio H (1996) Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta. Biochem Pharmacol 51: 403-411.","DOI":"10.1016\/0006-2952(95)02184-1"},{"key":"10.1124\/mol.108.053660_bib10","doi-asserted-by":"crossref","unstructured":"Hosseinpour F, Ellfolk M, Norlin M, and Wikvall K (2007) Phenobarbital suppresses vitamin D3 25-hydroxylase expression: a potential new mechanism for drug-induced osteomalacia. Biochem Biophys Res Commun 357: 603-607.","DOI":"10.1016\/j.bbrc.2007.03.177"},{"key":"10.1124\/mol.108.053660_bib11","doi-asserted-by":"crossref","unstructured":"Lou YR, Laaksi I, Syv\u00e4l\u00e4 H, Bl\u00e4uer M, Tammela TL, Ylikomi T, and Tuohimaa P (2004) 25. -hydroxyvitamin D3 is an active hormone in human primary prostatic stromal cells. FASEB J 18: 332-334.","DOI":"10.1096\/fj.03-0140fje"},{"key":"10.1124\/mol.108.053660_bib12","doi-asserted-by":"crossref","unstructured":"Marden NY, Fiala-Beer E, Xiang SH, and Murray M (2003) Role of activator protein 1 in the down-regulation of the human CYP2J2 gene in hypoxia. Biochem J 373: 669-680.","DOI":"10.1042\/bj20021903"},{"key":"10.1124\/mol.108.053660_bib13","doi-asserted-by":"crossref","unstructured":"Marzolini C, Telenti A, Decosterd LA, Greub G, Biollaz J, and Buclin T (2001) Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients. AIDS 15: 71-75.","DOI":"10.1097\/00002030-200101050-00011"},{"key":"10.1124\/mol.108.053660_bib14","doi-asserted-by":"crossref","unstructured":"Moghadasian MH, Salen G, Frohlich JJ, and Scudamore CH (2002) Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations. Arch Neurol 59: 527-529.","DOI":"10.1001\/archneur.59.4.527"},{"key":"10.1124\/mol.108.053660_bib15","doi-asserted-by":"crossref","unstructured":"Nishimura M, Yoshitsugu H, Naito S, and Hiraoka I (2002) Evaluation of gene induction of drug-metabolizing enzymes and transporters in primary culture of human hepatocytes using high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi 122: 339-361.","DOI":"10.1248\/yakushi.122.339"},{"key":"10.1124\/mol.108.053660_bib16","doi-asserted-by":"crossref","unstructured":"Noreault TL, Kostrubsky VE, Wood SG, Nichols RC, Strom SC, Trask HW, Wrighton SA, Evans RM, Jacobs JM, Sinclair PR, et al. (2005) Arsenite decreases CYP3A4 and RXRalpha in primary human hepatocytes. Drug Metab Dispos 33: 993-1003.","DOI":"10.1124\/dmd.105.003954"},{"key":"10.1124\/mol.108.053660_bib17","doi-asserted-by":"crossref","unstructured":"Ohyama Y and Yamasaki T (2004) Eight cytochrome P450s catalyze vitamin D metabolism, Front Biosci 9: 3007-3018.","DOI":"10.2741\/1455"},{"key":"10.1124\/mol.108.053660_bib18","doi-asserted-by":"crossref","unstructured":"Pascussi JM, Robert A, Nguyen M, Walrant-Debray O, Garabedian M, Martin P, Pineau T, Saric J, Navarro F, Maurel P, et al. (2005) Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest 115: 177-186.","DOI":"10.1172\/JCI21867"},{"key":"10.1124\/mol.108.053660_bib19","doi-asserted-by":"crossref","unstructured":"Prosser DE and Jones G (2004) Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 29: 664-673.","DOI":"10.1016\/j.tibs.2004.10.005"},{"key":"10.1124\/mol.108.053660_bib20","doi-asserted-by":"crossref","unstructured":"Shinkyo R, Sakaki T, Kamakura M, Ohta M, and Inouye K (2004) Metabolism of vitamin D by human microsomal CYP2R1. Biochem Biophys Res Commun 324: 451-457.","DOI":"10.1016\/j.bbrc.2004.09.073"},{"key":"10.1124\/mol.108.053660_bib21","doi-asserted-by":"crossref","unstructured":"Theodoropoulos C, Demers C, Petit JL, and Gascon-Barre M (2003) High sensitivity of rat hepatic vitamin D3 25-hydroxylase CYP27A to 1,25-dihydroxyvitamin D3 administration. Am J Physiol Endocrinol Metab 284: E138-E147.","DOI":"10.1152\/ajpendo.00303.2002"},{"key":"10.1124\/mol.108.053660_bib22","doi-asserted-by":"crossref","unstructured":"Tokar EJ and Webber MM (2005) Chemoprevention of prostate cancer by cholecalciferol (vitamin D3): 25-hydroxylase (CYP27A1) in human prostate epithelial cells. Clin Exp Metastasis 22: 265-273.","DOI":"10.1007\/s10585-005-8394-y"},{"key":"10.1124\/mol.108.053660_bib23","doi-asserted-by":"crossref","unstructured":"Wang X and Seed B (2003) A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 31: e154.","DOI":"10.1093\/nar\/gng154"},{"key":"10.1124\/mol.108.053660_bib24","doi-asserted-by":"crossref","unstructured":"Xu Y, Hashizume T, Shuhart MC, Davis CL, Nelson WL, Sakaki T, Kalhorn TF, Watkins PB, Schuetz EG, and Thummel KE (2006) Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1\u03b1,25-dihydroxyvitamin D3: implications for drug-induced osteomalacia. Mol Pharmacol 69: 56-65.","DOI":"10.1124\/mol.105.017392"},{"key":"10.1124\/mol.108.053660_bib25","doi-asserted-by":"crossref","unstructured":"Zhou C, Assem M, Tay JC, Watkins PB, Blumberg B, Schuetz EG, and Thummel KE (2006) Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest 116: 1703-1712.","DOI":"10.1172\/JCI27793"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24019576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24019576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.108.053660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:35:35Z","timestamp":1739957735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24019576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0026895X24019576"],"URL":"https:\/\/doi.org\/10.1124\/mol.108.053660","relation":{},"ISSN":["0026-895X"],"issn-type":[{"type":"print","value":"0026-895X"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of Human Vitamin D3 25-Hydroxylases in Dermal Fibroblasts and Prostate Cancer LNCaP Cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.108.053660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}